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Does blood pressure variability contribute to risk
stratification? Methodological issues and a review of
outcome studies based on home blood pressure
Kei Asayama1,2, Fang-Fei Wei1,3, Yan-Ping Liu1, Azusa Hara1, Yu-Mei Gu1, Rudolph Schutte1,4, Yan Li3,
Lutgarde Thijs1 and Jan A Staessen1,5
This review addresses methodological issues in the assessment of blood pressure variability and the predictive value of blood
pressure variability derived from blood pressure readings obtained in the relaxed home environment. Preference should be given
to indexes of blood pressure variability that are independent of the mean because we should evaluate the impact of blood
pressure variability by eliminating the effect of blood pressure levels. Beat-to-beat blood pressure recordings outperform home
blood pressure measurement in the assessment of blood pressure variability in longitudinal Belgian and Japanese population
studies, whereas blood pressure variability did not incrementally predict outcome beyond blood pressure level and other
cardiovascular risk factors. In conclusion, clinicians should focus on blood pressure level, given that it is the predominant risk
factor and is manageable by lifestyle modifications and adequate antihypertensive drug treatment. Blood pressure variability
remains a research tool that requires further prospective studies with hard end points to define its potential application, as it
may be potentially useful in daily clinical practice.
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INTRODUCTION
Home blood pressure measurements have the advantage of being
obtained in a relatively standardized and relaxed environment. More-
over, self-measurement is well accepted by patients and encourages
active participation in the management of hypertension.1–5 Compared
with conventional office blood pressure measurement, home blood
pressure allows for a greater number of readings and minimizes the
white coat effect, observer bias and measurement error, thereby
contributing to enhanced diagnostic accuracy. Adjustment of anti-
hypertensive medication based on home blood pressure readings
might also reduce health-care costs.6 In addition, home blood pressure
measurement offers several of the well-recognized advantages of the
more complex approach of ambulatory blood pressure monitoring.4,5,7
Blood pressure variability has been a hot topic as some investigators
have argued that stroke risk could be reduced more effectively by
targeting systolic blood pressure variability along with systolic blood
pressure level.8–10 We searched the PubMed database using ‘blood
pressure fluctuation’ OR ‘blood pressure instability’ OR ‘blood
pressure variability’ OR ‘blood pressure variation’ AND ‘1980/01/
01’[Date—Publication]: ‘2014/05/30’[Date—Publication] as initial
search terms, yielding 2066 publications. The number of publications
was stable from 2010 to 2012 (113, 114 and 110 publications in 2010,
2011 and 2012, respectively). However, the number of publications
increased to 175 in 2013. Similar to visit-to-visit variability in
conventional clinic blood pressure measurements,9 multiple home
blood pressure readings11–13 can provide information on blood
pressure variability over varying time periods. The issue of whether
naturally occurring blood pressure variability predicts risk beyond
blood pressure level remains debated.
ESTABLISHED AND NEWLY DEVELOPED INDEXES OF BLOOD
PRESSURE VARIABILITY
Short-term blood pressure variability measured on one occasion was
reported in the early 1970s.14 In this report, Clement et al.14 assessed
blood pressure variability using s.d. and coefficient of variation (CV)
values obtained every 5min for 3 h in 70 untreated hypertensive
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patients. These researchers identified a positive association between
sympathetic activity and the s.d. of blood pressure. However, blood
pressure level and s.d. were correlated; thus, the correlations of
variability with the indexes of sympathetic activity disappeared when
variability was expressed as CV. In the early 1980s, Mancia15
performed continuous intravascular recordings for 24 h in 25
untreated hypertensive patients. This study revealed that the s.d. was
significantly reduced after antihypertensive drug intervention, whereas
the CV was not.15 Nevertheless, the results can still be influenced by
the blood pressure level.8,9
Mena et al.16 proposed average real variability (ARV) as a novel
index representing short-tem, reading-to-reading, within-subject
variability in blood pressure. ARV attempts to correct for the
limitations of the commonly used s.d., which accounts only for the
dispersion of values around the mean and not for the order of the
blood pressure readings.17,18 ARV is calculated using the following
formula:
ARV ¼ 1P
wk
Xn1
k¼1
wk ´ BPkþ1  BPkj j
where n is the number of blood pressure readings, k ranges from 1 to
n− 1 and wk is the time interval between BPk and BPk+1. ARV
therefore accounts for the order of the measurements and weighs each
value according to the measurement interval. However, ARV remains
correlated with the blood pressure levels.
Rothwell et al.8,9 proposed blood pressure variability independent of
the mean (VIM) as a new index, which might serve as a better
predictor of cardiovascular outcome. VIM is calculated as the s.d.
divided by the mean to the power x and multiplied by the population
mean to the power x. The power x is obtained by fitting a curve
through a plot of s.d. against mean using the model s.d.= a×meanx,
where x is derived by nonlinear regression analysis. Because VIM is
derived from the distribution of the blood pressure values in each
population, VIM is tied to the population being examined and cannot
be compared across the population. A strong correlation is noted for
VIM and other indexes of blood pressure.19 Nevertheless, VIM does
not correlate with blood pressure levels,8,9 assuring that we are able to
evaluate the impact of blood pressure variability using VIM by
eliminating the effect of blood pressure levels.
The concept of blood pressure variability is wide ranging and
extends beyond reading-to-reading variability. The diurnal blood
pressure profile normally includes a 10–20% fall in blood pressure
during sleep, which is driven by physical inactivity and mostly
independent of an endogenous rhythm.20 Based on the International
Database on Ambulatory blood pressure monitoring in relation to
Cardiovascular Outcomes (IDACO) project, we reported that after
adjustment for cardiovascular risk factors and the 24-h blood pressure,
the night-to-day ratio predicted total, cardiovascular and noncardio-
vascular mortality, but not fatal combined with nonfatal cardiovas-
cular events.21 Kario et al.22 proposed the definitions of the sleep-
trough and preawakening morning surge in blood pressure, which are
independent predictors of stroke in elderly Japanese hypertensive
patients. Their findings were supported by the Ohasama study
involving 1430 individuals from the general population, which
revealed that these factors predicted cerebral hemorrhage (quintile
trend P= 0.04) but not ischemic stroke (quintile trend P= 0.94).
However, Verdecchia et al.23 reported that neither patients with a high
sleep-trough (436.0mmHg) nor those with a high preawakening
(427.5mmHg) systolic pressure had independent risks for mortality
and cardiovascular events. The IDACO analysis demonstrated that an
exaggerated morning surge (⩾90th percentile of the population) is an
independent risk factor for mortality as well as cardiovascular and
cardiac events, whereas a sleep-trough or preawakening morning surge
in systolic blood pressure o20mmHg is not.24 All of these hetero-
geneous forms of blood pressure variation reflect different biological
phenomena that exhibit low correlation among these processes.25
VARIABILITY OF HOME BLOOD PRESSURE MEASURED BY
OBSERVERS
The clinical usefulness of blood pressure variability beyond blood
pressure levels should be evaluated by assessing hard outcomes. Based
on the Flemish Study on Environment, Genes and Health Outcomes
(FLEMENGHO) study,26 we investigated the predictive value of home
blood pressure variability in 2944 participants (mean age, 44.9 years;
50.7% women).27 At baseline, trained nurses measured each partici-
pant’s blood pressure at two home visits during an interval of
2–4 weeks. At each home visit, the nurses obtained five consecutive
blood pressure readings to the nearest 2 mmHg using mercury
sphygmomanometers after the participants rested for 5min in the
sitting position. A stringent program for quality assurance and quality
control was implemented.28 Every 3 months, the observers were
required to pass a test that involved reading blood pressures from a
videotape featuring a falling mercury column with Korotkoff sounds.
Their readings were required to comply within 5mmHg of those of
senior medical staff. Digit preference was assessed at 6-month
intervals.
We assessed within-subject overall (10 readings), within- and
between-visit systolic blood pressure variability using VIM, maximum
minus minimum blood pressure difference (MMD) and ARV. During
a median follow-up of 12.3 years (5th to 95th percentile interval,
2.7–23.7 years), 401 deaths occurred, and 311 participants experienced
a fatal or nonfatal cardiovascular event. Overall systolic blood pressure
variability averaged 5.45 U, 15.87mmHg and 4.08mmHg for VIM,
MMD and ARV, respectively. Women, older age, higher systolic blood
pressure, lower body mass index, a history of peripheral arterial
disease and use of β-blockers were the main correlates of systolic blood
pressure variability. In multivariable-adjusted analyses, including both
systolic blood pressure and a measure of variability, systolic blood
pressure predicted the outcomes, whereas any measure of variability
did not. To assess the additional risk explained in the Cox regression
model, we applied the generalized R2 statistic29 by adding the indices
of blood pressure variability to models already including the systolic
blood pressure level and covariables; the R2 statistics were ⩽ 0.10%.
The 10-year multivariable-adjusted risk of a composite cardiovascular
event increased with systolic blood pressure (Po0.0001) but not with
overall VIM (P= 0.31), and the results for the risk of death were
similar. These findings suggest that within-subject blood pressure
variability measured by an observer does not exhibit any prognostic
significance beyond systolic pressure levels in the general population.
VARIABILITY OF SELF-MEASURED HOME BLOOD PRESSURE
Several Japanese groups have assessed the relation between target-
organ damage or the incidence of cardiovascular complications and
blood pressure variability as captured by self-measurements at home.
Ushigome et al.30 demonstrated significant correlations between
macroalbuminuria in type 2 diabetes mellitus and the CV of home
blood pressure readings. Using a multivariable-adjusted linear regres-
sion analysis including blood pressure level, these authors recently
reported that pulse wave velocity was significantly correlated with the
s.d. of three consecutive measurements on one occasion in the
morning (P= 0.016) or evening (P= 0.0099) but not with the s.d. of
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day-to-day home blood pressure readings (P⩾ 0.78).31 Nishimura
et al.32 demonstrated that a low estimated glomerular filtration rate
was significantly associated with the s.d. of home blood pressure
readings. Researchers have placed expectations on home blood
pressure variability as a biomarker for chronic kidney disease.33
However, as reported by Okada et al.,34 s.d., CV and ARV of self-
measured home blood pressure readings did not predict the progres-
sion of chronic kidney disease.
The prognostic significance of self-measured home day-to-day
blood pressure variability was first assessed in the Ohasama population
using the within-participant s.d. of morning systolic blood pressure
readings over 26 days (median).13 In multivariable-adjusted Cox
models also including blood pressure level, the s.d. was associated
with higher risks of total mortality (hazard ratio (HR) per 1 s.d.
increase in the within-participant s.d., 1.18; 95% confidence intervals,
1.07–1.31), cardiovascular mortality (HR, 1.20; CI, 1.02–1.40), non-
cardiovascular mortality (HR, 1.18; CI, 1.04–1.34) and stroke mortal-
ity (HR, 1.38; CI, 1.12–1.72). The association was not observed for
cardiac mortality (HR, 1.02; CI, 0.89–1.29). The association of blood
pressure variability with non-cardiovascular mortality was difficult to
interpret but might reflect reverse causality (i.e., subclinical disease
leading to greater variability). The Finn-Home investigators assessed
the day-to-day variability of the self-measured systolic blood pressure
readings in the morning. The within-participant s.d. over 7 days
predicted total mortality and cardiovascular events.35 The HRs for an
1-s.d. increment in variability (3.93 mmHg) were 1.17 (CI, 1.00–1.30;
P= 0.03) and 1.21 (CI, 1.08–1.40; P= 0.006), respectively.35 Day-to-
day variability in the evening systolic blood pressure readings was not
predictive (PX0.11).35
Based on the self-measured home blood pressure readings, we
explored whether fatal and nonfatal outcomes were associated with the
new indexes of blood pressure variability.7 We analyzed mortality and
stroke risk in 2421 Ohasama residents after excluding high-risk
participants with a history of stroke. In the Ohasama study, physicians
and public health nurses instructed participants how to measure their
home blood pressure using a validated36 oscillometric device
(OMRON HEM 401C; Omron Healthcare, Kyoto, Japan). Participants
were asked to record their blood pressure for 4 weeks after at least
2 min of rest in the morning within 1 h after awakening and, if
applicable, before taking their blood pressure-lowering medications.
Participants also obtained the recordings in the evening, immediately
before going to bed. We assessed the independent predictive value of
the within-subject mean systolic blood pressure and corresponding
variability indexes, namely VIM, MMD and ARV. Over a median
follow-up of 12.0 years, 412 participants died with any cause, 139
attributed to cardiovascular causes death and 223 participants had a
stroke. In multivariable-adjusted Cox models including the morning
systolic pressure and other covariates, VIM and ARV predicted total
and cardiovascular mortality in all participants (P⩽ 0.044), whereas
VIM predicted cardiovascular mortality in treated (P= 0.014) but not
in untreated (P= 0.23) participants. Morning MMD was not pre-
dictive of any end points (P⩾ 0.085). In models that already included
evening systolic pressure, only VIM predicted cardiovascular mortality
in all patients as well as untreated participants (P⩽ 0.046). Both
morning and evening systolic blood pressure were consistent pre-
dictors (P⩽ 0.032) with the exception of cardiovascular mortality in
treated participants for morning systolic pressure (P= 0.082) when we
calculated the multivariable-adjusted 10-year risk of cardiovascular
mortality and stroke incidence in relation to the mean level and VIM
(Figure 1 in all of the participants). The R2 statistic,29 which was also
calculated in the above-mentioned FLEMENGHO population,27
ranged from o0.01 to 0.88%. Being on antihypertensive drug
treatment appears to be the main driver of the significant associations
between cardiovascular mortality and blood pressure variability.7 In
the Japanese population sample, the new indexes of blood pressure
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Figure 1 Absolute 10-year risk of cardiovascular mortality (a) and stroke incidence (b) in relation to the mean level of systolic blood pressure measured at
home in the morning in 2421 participants. The analyses were standardized to the distributions (mean or ratio) of sex, age, body mass index, heart rate,
smoking and drinking, total cholesterol, diabetes mellitus, history of cardiovascular diseases and treatment with antihypertensive drugs. Four continuous lines
equal to 3, 6, 9 and 12U represent the risk that is independently associated with VIM. P-values represent the independent effects of SBP (PSBP) and VIM
(PVIM). np and ne indicate the number of participants at risk and the number of events. Reproduced from Asayama et al.7
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variability derived from self-measured home blood pressure readings
did not incrementally predict outcome beyond mean systolic pressure.
VARIABILITY DERIVED FROM BEAT-TO-BEAT BLOOD
PRESSURE READING
Few studies have addressed the risk associated with blood pressure
variability as captured by beat-to-beat recordings. Parati et al.37
recorded continuous intra-arterial blood pressure for 24 h in 108
untreated hospitalized patients (mean age, 43.8 years; 44.4% women).
Target-organ damage was assessed from the electrocardiographic
Sokolow–Lyon index, radiographic cardiac volume, Keith–Wagener’s
classification of retinal lesions and a history of cardiovascular or renal
complications. In analyses by quintiles of the 24-h continuous blood
pressure level, patients whose blood pressure variability was below
average in each quintile had a lower prevalence and severity of target-
organ damage than those with a higher than average blood pressure
variability.37 Veerman et al.38 studied 33 hypertensive patients (mean
age, 41 years; 48.5% women) who were off treatment for at least
3 months. Blood pressure was recorded using the Finapres Model 5 for
20min with participants in the supine position. The logarithmically
transformed urinary albumin-to-creatinine ratio correlated with
diastolic (r= 0.37; P= 0.037) but not with systolic blood pressure
variability as measured by the s.d.38 The associations of left ventricular
mass index with systolic and diastolic blood pressure variability were
not significant.38 The drawbacks of these previous studies37,38 include
the use of s.d. as a measure of blood pressure variability,37 small
sample size,37,38 selection of hospitalized participants37 and the use of
dichotomized instead of continuous variability indexes in
multivariable-adjusted analyses.37
Recently, Wei et al.39 assessed target-organ damage markers and
new indexes of blood pressure variability based on 10-min beat-to-
beat, 24-h ambulatory and 7-day home blood pressure recordings
among 256 Chinese outpatients (mean age, 51.1 years) who were all
off blood pressure-lowering treatment. The patients’ beat-to-beat
finger blood pressures were recorded for 10min after participants
rested for at least 10min in the supine position. The recordings were
obtained with the Finometer PRO device (Finapres Medical System
BV, Amsterdam, The Netherlands) using the volume-clamp method.40
Target-organ damage was assessed from aortic pulse wave velocity, left
ventricular hypertrophy and the urinary albumin-to-creatinine ratio.
In unadjusted categorical analyses across quartiles of mean systolic
blood pressure levels (Figure 2), VIM did not correlate with pressure
level (P⩾ 0.28) regardless of the type of blood pressure recording.
With the exception of the MMD in beat-to-beat recordings (P= 0.21),
MMD and ARV positively correlated with pressure level (P⩽ 0.007)
across quartiles of systolic blood pressure. In multiple regression
analysis, left ventricular mass index was not associated with mean
systolic pressure levels in beat-to-beat recordings (P⩾ 0.18) but was
positively associated (Po0.038) with VIM (+3.144 gm− 2), MMD
(+3.528 gm− 2) and ARV (+2.968 gm− 2) independently of systolic
blood pressure and other covariables. The urinary albumin-to-
creatinine ratio positively associated (P⩽ 0.03) with the level of mean
systolic blood pressure (+1.169mgmmol− 1) and MMD (+1.183
mgmmol− 1), and pulse wave velocity only associated with the level
of systolic pressure (+0.689m s− 1; Po0.001). We assessed the
variance inflation factor in all models including both level and
variability of beat-to-beat blood pressure. The variance inflation factor
did not exceed 1.24, indicating minimal collinearity. In 24-h and
home blood pressure recordings, the indexes of target-organ damage
positively associated (Po0.05) with the level of pressure but were not
consistently associated with the indexes of blood pressure variability.
Beat-to-beat recordings may therefore outperform home and 24-h
ambulatory blood pressure monitoring in the assessment of target-
organ damage in relation to blood pressure variability. The opposite
might be true for evaluating the contribution of blood pressure levels
to target-organ damage. However, only surrogate end points in cross-
sectional studies have been assessed for association with level and
variability in beat-to-beat blood pressure recordings.37,38 Only
one prospective study addressed the incidence of cardiovascular
complications in relation to blood pressure levels as assessed by home
invasive intra-arterial 24-h ambulatory recordings in hypertensive
patients, but this study did not provide information regarding blood
pressure variability.41,42 Based on the findings from the Northwick
Park Heart Study,39,40 one might speculate that the ability of
beat-to-beat recordings to demonstrate associations with target-
organ damage might depend on the recording technique (intra-arterial
vs. finger plethysmography) and the duration of the recordings
(10min vs. 24 h).
CONCLUSION
Blood pressure variability should preferably be assessed by indexes that
are independent of blood pressure level, such as VIM.8,9 Even when
we observe a significant prognostic effect of s.d. or other variability
indexes, we cannot conclude the usefulness of blood pressure
variability because it is affected by the level. However, recent studies
of home blood pressure variability as captured by VIM failed to
Figure 2 Variability independent of the mean (VIM; a), maximum–minimum difference (MMD; b) and average real variability (ARV; c) by quartiles of the
distribution of the mean systolic blood pressure (SBP) for 24-h (&), home (J) or beat-to-beat (Δ) measurements. P-values represent the linear trends across
the quartiles of SBP. Reproduced from Wei et al.39
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demonstrate that blood pressure variability substantially refines risk
profiling beyond blood pressure levels;7,27 therefore, it is less mean-
ingful to consider variability indexes for risk stratification. Blood
pressure level, the predominant risk factor manageable by lifestyle
modifications and adequate antihypertensive drug treatment43 should
remain the primary focus for risk stratification and treatment in
clinical practice. Blood pressure variability currently remains a
research tool that requires further prospective studies with hard end
points to define potential applications, where it might be useful in
daily clinical practice.
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